ScienceDaily recently reported on the promising findings by a team of researchers at the Huck Institute of Life Sciences at Penn State to tackle the increasingly important fight against antimicrobial resistance. According to Valerie Morley, a postdoctoral scholar involved in the study, a leading cause of antibiotic-resistant infections in the healthcare setting is Vancomycin-Resistant (VR) Enterococcus faecium. This opportunistic pathogen can colonize the gastrointestinal (GI) tract and cause sepsis and endocarditis when introduced to sites like the bloodstream or spine.

One of the few remaining antibiotics to effectively treat VR E. faecium is daptomycin – however these bacteria are quickly becoming resistant to daptomycin as well; particularly in those whose GI tract is colonized. When daptomycin is given systemically and reaches the gut, it allows the VR E. faecium to develop genetic mutations that increase resistance and causes the drug to be shed through fecal matter. To combat this, the scientists orally administered an adjuvant treatment called cholestyramine which is an FDA-approved bile-acid sequestrant.

Cholestyramine binds to daptomycin and acts as an “anti-antibiotic” to prevent the drug from being active the gut and thus reduces the likelihood of antimicrobial resistant organisms in the GI to develop resistance to daptomycin. This experiment in mice models resulted in an 80-fold reduction of the fecal-shedding of daptomycin. Amit Pai, the chair of the Department of Clinical Pharmacy at the University of Michigan states that current strategies such as combination therapy or reduced use of antibiotics do not translate well to interventions that can be used on an individual-level and believes that “reducing selective antibiotic pressure on bacteria that reside in the colon is a potential individual-level strategy that deserves greater attention.”

Treating COVID-19 may increase antibiotic resistance

According to a study shared by Medical News...

Ontario scientist thinks old drugs could become our new antibiotics

As the world loses its upper hand in the...

Engineered bacteria could help protect ‘good’ gut microbes from antibiotics

Engineered bacteria could help protect ‘good’...

5 key factors expected to bring the total knee replacement market value to $14.9B by 2030

5 key factors expected to bring the total knee...

Knee replacement in folks over 80: Less risky than you think

Knee replacement in folks over 80: Less risky...

Still not enough antibiotics in the works to fight superbugs, WHO says

In a new report shared by Becker’s Hospital...

Assumptions of how antibiotics work may be incorrect

Bacterial infections are the No. 1 cause of...

Distribuidor exclusivo.

0